Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTNM
EOLS
Add up to 3 more stocks
CTNM
Contineum Therapeutics, Inc.
-1.42%
$12.54-0.18Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$471.77M
52W Range
$8.60 - $17.79
EOLS
Evolus, Inc.
-1.34%
$7.37-0.10Delayed quote: Oct 6, 2026, 2:10 PM EDT
Market Cap
$485.35M
52W Range
$3.86 - $9.31
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.97 | N/A |
| P/S Ratio | N/A | 1.53 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 66.3% |
| Operating Margin | 0.0% | -7.3% |
| Net Margin | 0.0% | -10.8% |
| ROE | -24.0% | N/A |
| ROA | -23.0% | -13.8% |
| ROIC | -27.2% | -15.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 37.17 | 1.70 |
| Quick Ratio | 37.17 | 1.28 |
| Debt/Equity | 0.03 | N/A |
| Interest Coverage | N/A | -1.91 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.